Stockscreener 앱 받기
27.70
1.78%
0.485
시간 외 거래:
27.50
-0.205
-0.74%
전일 마감가:
$27.22
열려 있는:
$27.16
하루 거래량:
612.54K
Relative Volume:
0.77
시가총액:
$1.20B
수익:
$78.02M
순이익/손실:
$-73.37M
주가수익비율:
-20.99
EPS:
-1.32
순현금흐름:
$-62.06M
1주 성능:
+16.65%
1개월 성능:
+24.46%
6개월 성능:
+134.19%
1년 성능:
+0.00%
1일 변동 폭
$26.00
$28.41
1주일 범위
$23.45
$30.47
52주 변동 폭
$8.89
$30.47
Beta Bionics Inc Stock (BBNX) Company Profile
명칭
Beta Bionics Inc
전화
949-427-7785
주소
11 HUGHES, IRVINE
BBNX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BBNX
Beta Bionics Inc
|
27.70 | 1.20B | 78.02M | -73.37M | -62.06M | -1.32 |
|
ABT
Abbott Laboratories
|
123.84 | 214.96B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
98.59 | 149.24B | 19.35B | 2.78B | 3.49B | 1.8696 |
|
SYK
Stryker Corp
|
358.16 | 136.23B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
90.20 | 116.33B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
83.07 | 48.41B | 5.88B | 1.34B | 577.90M | 2.3455 |
Beta Bionics Inc Stock (BBNX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-10-21 | 재개 | Stifel | Buy |
| 2025-10-01 | 업그레이드 | Goldman | Neutral → Buy |
| 2025-06-16 | 개시 | Truist | Buy |
| 2025-06-12 | 개시 | Lake Street | Buy |
| 2025-05-30 | 개시 | Goldman | Neutral |
| 2025-05-30 | 개시 | Wolfe Research | Outperform |
| 2025-02-24 | 개시 | BofA Securities | Buy |
| 2025-02-24 | 개시 | Lake Street | Buy |
| 2025-02-24 | 개시 | Leerink Partners | Outperform |
| 2025-02-24 | 개시 | Piper Sandler | Overweight |
| 2025-02-24 | 개시 | Stifel | Buy |
| 2025-02-20 | 개시 | Ladenburg Thalmann | Neutral |
| 2025-02-20 | 개시 | Robert W. Baird | Neutral |
모두보기
Beta Bionics Inc 주식(BBNX)의 최신 뉴스
Beta Bionics Announces Participation at Upcoming Investor Conferences - The Manila Times
Beta Bionics (BBNX) Q3 2025 Earnings Transcript - AOL.com
Beta Bionics Inc. (BBNX.US): Solid 3Q’25 Results But Valuation Full at Current Levels - Smartkarma
Published on: 2025-11-03 07:57:20 - newser.com
Will Beta Bionics Inc. price bounce be sustainableJuly 2025 Catalysts & Detailed Earnings Play Strategies - newser.com
Beta Bionics Inc. stock chart pattern explained2025 Top Gainers & Scalable Portfolio Growth Methods - newser.com
Is now a turning point for Beta Bionics Inc.Gap Down & Verified Stock Trade Ideas - newser.com
Is Beta Bionics Inc. stock positioned for long term growth2025 Geopolitical Influence & Fast Entry Momentum Trade Alerts - newser.com
Regression analysis insights on Beta Bionics Inc. performanceTrade Analysis Report & Verified Entry Point Signals - newser.com
What drives Beta Bionics Inc stock priceMean Reversion Trades & Rapid Portfolio Appreciation - earlytimes.in
Analyzing Beta Bionics Inc. with multi timeframe chartsIPO Watch & Target Return Focused Picks - newser.com
Will Beta Bionics Inc. continue its uptrendJuly 2025 Pullbacks & Low Drawdown Investment Strategies - newser.com
Will a bounce in Beta Bionics Inc. offer an exitJuly 2025 Setups & Verified Momentum Stock Watchlist - newser.com
Beta Bionics, Inc. (NASDAQ:BBNX) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Beta Bionics, Inc. (NASDAQ:BBNX) Sees Significant Drop in Short Interest - MarketBeat
Beta Bionics (NASDAQ:BBNX) Upgraded by Wall Street Zen to Hold Rating - MarketBeat
Leerink Partnrs Predicts Higher Earnings for Beta Bionics - MarketBeat
Beta Bionics, Inc. (BBNX) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
Beta Bionics raises 2025 revenue guidance to $96.5M and projects Q4 gross margin improvement amid pharmacy channel expansion - MSN
Beta Bionics, Inc. (BBNX) Reports Q3 Earnings: What Key Metrics Have to Say - MSN
Comparing Beta Bionics Inc. in custom built stock radarsJuly 2025 Analyst Calls & Verified Momentum Stock Ideas - newser.com
Published on: 2025-10-31 02:01:27 - newser.com
Midday Stock Roundup: BJ’s Surges After Earnings top Estimates - Orange County Business Journal
Is Beta Bionics Inc. stock attractive for retirement portfoliosEarnings Growth Report & Free Expert Verified Stock Movement Alerts - newser.com
Beta Bionics Inc (BBNX) Q3 2025 Earnings Call Highlights: Record Growth and Strategic Challenges By GuruFocus - Investing.com Canada
Beta Bionics Reports Strong Q3 Growth and Raises Guidance - MSN
Beta Bionics (BBNX) Valuation Concerns Mount as Forecast Revenue Growth Far Exceeds Market Average - Yahoo Finance
Beta Bionics Reports Strong Q3 Growth Amid Challenges - MSN
Beta Bionics' (BBNX) "Overweight" Rating Reaffirmed at Piper Sandler - MarketBeat
Beta Bionics (NASDAQ:BBNX) Reaches New 1-Year High After Earnings Beat - MarketBeat
Beta Bionics’ iLet Experience Study: A Game-Changer in Diabetes Management? - MSN
Beta Bionics, Inc. (NASDAQ:BBNX) Released Earnings Last Week And Analysts Lifted Their Price Target To US$28.10 - Yahoo Finance
Beta Bionics, Inc. (NASDAQ:BBNX) Stocks Shoot Up 35% But Its P/S Still Looks Reasonable - 富途牛牛
BBNX Crosses Above Average Analyst Target - Nasdaq
Beta Bionics, Inc. (NASDAQ:BBNX) Looks Just Right With A 35% Price Jump - simplywall.st
Goldman Sachs Maintains Beta Bionics (BBNX) Buy Recommendation - Nasdaq
Beta Bionics (NASDAQ:BBNX) Releases Earnings Results - MarketBeat
Truist Raises Price Target on Beta Bionics to $32 From $28, Keeps Buy Rating - MarketScreener
Beta Bionics price target raised to $31 from $26 at Stifel - TipRanks
Beta Bionics, Inc.Common Stock (NQ: BBNX - FinancialContent
Beta Bionics, Inc. (BBNX) stock price, news, quote and history - Yahoo! Finance UK
Beta Bionics Inc (BBNX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.84%
0.40%
자본화:
|
볼륨(24시간):